Alocane Emergency Burn Pads Swab
NDC Package 68229-403-03
Package Information
Alocane Emergency Burn Pads (lidocaine hydrochloride) swabs is a medication used as Topical Analgesic. This formulation utilizes a swab delivery system. Marketed by Quest Products, Inc., this product is identified by NDC 68229-403 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 1872886 - lidocaine HCl 4 % Medicated Pad
- RxCUI: 1872886 - lidocaine hydrochloride 40 MG/ML Medicated Pad
- RxCUI: 1872891 - ALOCANE 4 % Medicated Pad
- RxCUI: 1872891 - lidocaine hydrochloride 40 MG/ML Medicated Pad [Alocane]
- RxCUI: 1872891 - Alocane 4 % Medicated Pad
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68229 - Quest Products, Inc.
- 68229-403 - Alocane Emergency Burn Pads
- 68229-403-03 - 12 POUCH in 1 BOX / 3 mL in 1 POUCH (68229-403-01)
- 68229-403 - Alocane Emergency Burn Pads
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (68229-403). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68229-403-03 identifies a specific commercial package of 12 pouch in 1 box / 3 ml in 1 pouch (68229-403-01) of Alocane Emergency Burn Pads, a human over the counter drug labeled by Quest Products, Inc.. This swab is formulated for topical use and contains lidocaine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Quest Products, Inc. on February 13, 2017. The current certification is valid through December 31, 2026.
How is this Quest Products, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68229040303. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.